FFPE RNA/DNA Purification Plus Kit
Sequential isolation and purification of total RNA and genomic DNA from FFPE tissue samples
For research use only and NOT intended for in vitro diagnostics.
Formerly Cat. 25000
CE-IVDD marked diagnostic version available here
FFPE RNA/DNA Purification Plus Kit
Sequential isolation and purification of total RNA and genomic DNA from FFPE tissue samples
Register today to receive an exclusive 15% off* on your first order.
Overview
- Fast and easy processing using rapid spin-column format
- High yields and quality of nucleic acids
- Separate fractionation of RNA and DNA
- Isolate total RNA, from large rRNA down to microRNA (miRNA)
- No phenol or chloroform extractions
- Purified RNA is suitable for a variety of downstream applications, including Small RNA Sequencing. Find out more information on Norgen's NGS services
- Purification is based on spin column chromatography that uses Norgen’s proprietary resin separation matrix
Norgen’s FFPE RNA/DNA Purification Plus Kit provides a rapid method for the sequential isolation and purification of total RNA (including microRNA) and genomic DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples. The RNA and DNA are sequentially purified into separate fractions using this kit. Using formalin to fix tissues leads to crosslinking of the nucleic acids and proteins, and the process of embedding the tissue samples can also lead to fragmentation of the nucleic acids over time. Norgen’s FFPE RNA/DNA Purification Plus Kit provides conditions that allow for the partial reversing of the formalin modifications, resulting in a high quality and yield of nucleic acids. The kit is able to purify all sizes of RNA, from large mRNA and ribosomal RNA down to microRNA (miRNA) and small interfering RNA (siRNA), depending on the age of the FFPE tissue as the degree of fragmentation of the RNA will increase over time. The RNA is purified from other cellular components without the use of phenol or chloroform. The purified RNA is of the highest integrity, and can be used in a number of downstream applications including real time PCR, reverse transcription PCR, Northern blotting, RNase protection and primer extension, and expression array assays. The purified genomic DNA is also of the highest quality, and can be used in PCR reactions, sequencing, Southern blotting and SNP analysis.
Details
Supporting Data
Kit Specifications
|
|
Maximum Binding Capacity
|
Up to 35 μg RNA
Up to 10 μg DNA |
Maximum Column Loading Volume
|
600 μL
|
Size of RNA Purified
|
All sizes, including small RNA (< 200 nt) |
Maximum Amount of Starting Material |
4 sections <20 μM thick
10 mg of unsectioned block |
Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. The DNAse I and Proteinase K should be stored at -20°C upon arrival. This kit is stable for 1 year after the date of shipment.
Component | Cat. 54300 (50 preps) |
---|---|
Digestion Buffer A | 2 x 25 mL |
Buffer RL | 40 mL |
Enzyme Incubation Buffer A | 6 mL |
Wash Solution A | 2 x 38 mL |
Elution Solution A | 6 mL |
Elution Buffer F | 15 mL |
Proteinase K | 2 x 12 mg |
DNase I | 1 vial |
RNA Purification Micro Columns | 50 |
DNA Purification Micro Columns | 50 |
Collection Tubes | 100 |
Elution Tubes (1.7 mL) | 100 |
Product Insert | 1 |
Documentation
FAQs
Plus
Poor DNA or RNA recovery may be caused by one or more of the following:
- Incomplete lysis of cells or tissue.
Ensure that the appropriate amount of Digestion Buffer A and Proteinase K was used. Increase the incubation time. - Column has become clogged.
Do not exceed the recommended amounts of starting materials. The amount of starting material may need to be decreased if the column shows clogging below the recommended levels. See FAQ related to “Clogged Column” below. - An alternative elution solution was used.
It is recommended that the Elution Solution A and Elution Buffer F supplied with this kit be used for maximum RNA or DNA recovery. - Ethanol or Buffer RL was not added to the lysate.
Ensure that the appropriate amount of ethanol and Buffer RL is added to the lysate before binding to the column. - Ethanol was not added to the Wash Solutions.
Ensure that 90 mL of 96 - 100% ethanol is added to the supplied Wash Solution A prior to use. - Low nucleic acid content in cells or tissues used.
Different tissues and cells have different nucleic acid contents, and thus the expected yield of nucleic acid will vary greatly from these different sources. Please check literature to determine the expected nucleic acid content of your starting material.
Clogged columns may occur due to:
- Insufficient solubilization of cells or tissues.
Ensure that the appropriate amount of Digestion Buffer A with Proteinase K added was used. Increase the incubation time. - Maximum number of sections or amount of tissue exceeds kit specifications.
Refer to specifications to determine if the amount of starting material falls within kit specifications. - Clarified lysate was not used for the binding step.
Ensure that after the lysis step, the sample is centrifuged if significant precipitates are present, and that only the clarified lysate is used in subsequent steps. - Centrifuge temperature is too low.
Ensure that the centrifuge remains at room temperature throughout the procedure. Temperatures below 15°C may cause precipitates to form that can cause the columns to clog.
Eluted RNA can be degraded due to the following factors:
- FFPE sample is old.
The quality of RNA purified may drastically decrease in old samples. For best performance, freshly prepared samples are highly recommended. - RNase contamination.
RNases may be introduced during the use of the kit. Ensure proper procedures are followed when working with RNA. Please refer to “Working with RNA” at the beginning of this user guide. - Too long incubation of lysate at high temperature.
In order to maintain the integrity of the RNA, it is important that the procedure be performed according to the time indicated. This is especially important for the lysate preparation step when the sample is incubated at 55°C and 80°C for 15 minutes each. Incubation beyond the time indicated may lead to fragmentation of RNA. - Improper storage of the purified RNA.
For short term storage, RNA samples may be stored at –20°C for a few days. It is recommended that samples be stored at –70°C for longer term storage. - Prolonged incubation at 55°C.
In order to reverse formalin crosslinks, an incubation at 55°C is required which may lead to degraded RNA.
Nucleic acids may not be performing well in downstream applications due to the following:
- Nucleic acids were not washed 3 times with the provided Wash Solution.
Traces of salt from the binding step may remain in the sample if the column is not washed 3 times with Wash Solution. Salt may interfere with downstream applications, and thus must be washed from the column. - Ethanol carryover.
Ensure that the dry spin under the Column Wash procedure is performed, in order to remove traces of ethanol prior to elution. Ethanol is known to interfere with many downstream applications. - Formalin crosslink was not completely reversed.
Ensure sufficient incubation at 80°C or 90°C is performed to remove formalin crosslink.
The contamination with genomic DNA may be due to the use of large amounts of starting material. To address this issue, it is recommended to perform RNase-free DNase I digestion on the RNA sample after elution to remove genomic DNA contamination.
Citations
Title | Multiregion sequencing of sarcomatoid renal cell carcinoma arising from autosomal dominant polycystic kidney disease |
Journal | Molecular Genetics & Genomic Medicine. 2022. |
Authors | Elizabeth Lee, Peiyong Guan, Abner Herbert Lim, Jui Wan Loh, Grace Fangmin Tan, Tracy Loh, Dave Yong Xiang Ng, Jing Yi Lee, Shane Goh, Wei Liu, Cedric Chuan-Young Ng, Bin Tean Teh, Jason Yongsheng Chan |
Title | Decreased expression of miR-23b is associated with poor survival of endometrial cancer patients |
Journal | Research Square. 2022. |
Authors | Paweł K. Włodarski, Klaudia Klick, Tomasz M. Grzywa, Alicja Klinke, Aleksandra Mielniczuk, Jarosław Wejman, Joanna Ostrowska, Agata Gondek |
Title | Methodological Challenges of Digital PCR Detection of the Histone H3 K27M Somatic Variant in Cerebrospinal Fluid |
Journal | Pathol Oncology & Research. 2022. |
Authors | Zaytseva M, Usman N, Salnikova E, Sanakoeva A, Valiakhmetova A, Chervova A, Papusha L, Novichkova G, Druy A |
Title | The use of whole genome methylation scanning to define genes preferentially suppressed in African American Prostate Cancer |
Journal | Cancer Epidemiology, Biomarkers and Prevention. 2017. |
Authors | Farah Rahmatpanah, Kathleen McGuire, Michael Lilly, Michael McClelland and Dan Mercola |
Title | MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma |
Journal | The Laryngoscope. 2015. |
Authors | Massimo Re MD, Artan Çeka MD, Corrado Rubini MD, Luigi Ferrante PhD, Antonio Zizzi PhD, Federico M. Gioacchini MD, Michele Tulli MD, Liana Spazzafumo PhD, Stefano Sellari-Franceschini MD, Antonio D. Procopio MD, andFabiola Olivieri PhD |
Title | In-Vivo Fusion of Human Cancer and Hamster Stromal Cells Permanently Transduces and Transcribes Human DNA |
Journal | PLOS ONE. 2014. |
Authors | David M. Goldenberg, Robert J. Rooney, Meiyu Loo, Donglin Liu, Chien-Hsing Chang |
Title | The miRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-Suppressive Gene Prosaposin. |
Journal | The Journal of Biological Chemistry. 2014. |
Authors | Brian Ell, Qiong Qiu, Yong Wei, Laura Mercatali, Toni Ibrahim, Dino Amadori and Yibin Kang |
Title | Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis. |
Journal | Cancer Cell. 2013. |
Authors | Ell B, Mercatali L, Ibrahim T, Campbell N, Schwarzenbach H, Pantel K, Amadori D, Kang Y. |
Title | Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis. |
Journal | International Journal of Gynecology Pathology. 2012. |
Authors | Cossu-Rocca P, Contini M, Uras MG, Muroni MR, Pili F, Carru C, Bosincu L, Massarelli G, Nogales FF, De Miglio MR. |
Title | Factors affecting the yield of microRNAs from laser microdissectates of formalin-fixed tissue sections. |
Journal | BMC Research Notes. 2012. |
Authors | Patnaik SK, Kannisto E, Yendamuri S. |
Title | Overexpression of the Lung Cancer-Prognostic miR-146b MicroRNAs Has a Minimal and Negative Effect on the Malignant Phenotype of A549 Lung Cancer Cells. |
Journal | PLoS One. 2011. |
Authors | Patnaik S, Kannisto E, Mallick R, Yendamuri S. |